Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

NYSE: BHVN · IEX Real-Time Price · USD

35.98

+1.27 (3.66%)

At close: Jul 19, 2024, 4:00 PM

35.91

-0.07 (-0.19%)

After-hours: Jul 20, 2024, 12:58 PM EDT

BHVN Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	75.72	62.77	130.86	37.41	16.05
Research & Development	465.79	373.28	437.07	181.49	98.46
Operating Expenses	541.51	436.05	567.93	218.9	114.51
Operating Income	-541.51	-436.05	-567.93	-218.9	-114.51
Other Expense / Income	-22.58	-26.5	1.91	-6.47	4.16
Pretax Income	-518.93	-409.55	-569.84	-212.43	-118.67
Income Tax	-1.75	-1.38	0.44	1.37	0
Net Income	-517.18	-408.17	-570.28	-213.8	-118.67
Shares Outstanding (Basic)	82	71	45	39	39
Shares Outstanding (Diluted)	82	71	45	39	39
Shares Change	19.64%	59.14%	13.63%	-	-
EPS (Basic)	-6.89	-5.73	-12.75	-5.43	-3.01
EPS (Diluted)	-6.89	-5.73	-12.75	-5.43	-3.01
Free Cash Flow	-359.48	-334.77	-303.76	-146.78	-78.65
Free Cash Flow Per Share	-4.41	-4.70	-6.79	-3.73	-2.00
EBITDA	-512.22	-402.64	-568.46	-211.04	-118.6
Depreciation & Amortization	6.71	6.91	1.39	1.39	0.07
EBIT	-518.93	-409.55	-569.84	-212.43	-118.67

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).